Finance

Lists
Why is 524400 up 2,80%?
Dive Deeper
524400:BOM
Ishita Drugs and Industries Ltd
₹77,00
+2,80%
(+2,10) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524400...
Open
₹77,40
High
₹77,40
Low
₹77,00
Mkt. cap
230,25 m
Avg. vol.
1,52 k
Volume
22,00
P/E ratio
32,58
52-wk high
₹90,85
52-wk low
₹66,00
EPS
₹2,36
No. of employees
17
Open
₹77,40
High
₹77,40
Low
₹77,00
Mkt. cap
230,25 m
Avg. vol.
1,52 k
Volume
22,00
P/E ratio
32,58
52-wk high
₹90,85
52-wk low
₹66,00
EPS
₹2,36
No. of employees
17
News stories
From web sources and news partners
About Ishita Drugs and Industries Ltd
CEO-
Employees17
Founded1972
Headquarters-
SectorPharmaceutical industry
Websiteishitadrugs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
30,68 m
31,36 m
30,55 m
31,45 m
Cost of goods sold
18,96 m
20,88 m
44,64 m
17,25 m
Cost of revenue
18,96 m
20,88 m
44,64 m
17,25 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,30 m
3,61 m
3,70 m
3,74 m
Operating expense
10,14 m
9,37 m
-15,19 m
11,51 m
Total operating expenses
29,10 m
30,25 m
29,45 m
28,77 m
Operating income
1,58 m
1,11 m
1,11 m
2,69 m
Other non operating income
669,00 k
966,00 k
-2,77 m
363,00 k
EBT including unusual items
2,22 m
1,92 m
2,79 m
3,00 m
EBT excluding unusual items
2,22 m
1,92 m
2,79 m
3,00 m
Income tax expense
783,00 k
367,00 k
1,02 m
700,00 k
Effective tax rate
35,33%
19,09%
36,40%
23,32%
Other operating expenses
6,56 m
5,49 m
-19,06 m
7,27 m
Net income
1,43 m
1,56 m
1,77 m
2,30 m
Net profit margin
4,67%
4,96%
5,81%
7,32%
Earnings per share
-
-
-
-
Interest and investment income
-
-
4,45 m
-
Interest expense
-36,00 k
-154,00 k
-
-47,00 k
Net interest expenses
-36,00 k
-154,00 k
4,45 m
-47,00 k
Depreciation and amortization charges
274,00 k
275,00 k
171,79 k
498,00 k
EBITDA
1,86 m
1,38 m
1,36 m
2,94 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme